Abnormal Involuntary Movement Scale (AIMS)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
aims total score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • No Dyskinesia0–1
  • Mild to Moderate Dyskinesia2–13
  • Severe Dyskinesia14–28
Direct Clinical Answer

The Abnormal Involuntary Movement Scale (AIMS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include facial muscles. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Measures involuntary movements of tardive dyskinesia (TD) in patients receiving neuroleptic medications

Clinical Indication

The Abnormal Involuntary Movement Scale (AIMS) is indicated for bedside clinical practice to support Measures involuntary movements of tardive dyskinesia (TD) in patients receiving neuroleptic medications. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.

Formula & Variables:

Sum of items 1-7 (involuntary movements), items 8-10 assess global severity, incapacitation, and awareness

Input Parameters

NameTypeRequiredDescription
facial_musclesintegerYesFacial muscles and facial expression
lips_perioralintegerYesLips and perioral area
jawintegerYesJaw
tongueintegerYesTongue
upper_extremitiesintegerYesUpper extremities (arms, wrists, hands, fingers)
lower_extremitiesintegerYesLower extremities (legs, knees, ankles, feet)
trunk_movementsintegerYesTrunk movements (neck, shoulders, hips)
global_severityintegerYesGlobal severity of abnormal movements
incapacitationintegerYesIncapacitation due to abnormal movements
patient_awarenessintegerYesPatient's awareness of abnormal movements
current_problems_teethstringYesCurrent problems with teeth/dentures
dental_problems_interferestringYesDo dental problems interfere with movements?

Score Interpretation & Guidance

RangeStageDescription
0–1No DyskinesiaAbsent or questionable movements
2–13Mild to Moderate DyskinesiaPresence of tardive dyskinesia
14–28Severe DyskinesiaSignificant tardive dyskinesia

Evidence-Based References (EBM)

  • Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; 1976.
  • National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Psychopharmacology Research Branch, NIMH. 1976.

Related calculators